Reaction Details |
| Report a problem with these data |
Target | ADP-ribosylhydrolase ARH3 |
---|
Ligand | BDBM421626 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ARH3 Assay |
---|
IC50 | >150000±n/a nM |
---|
Citation | McGonagle, AE; Jordan, AM; Waszkowycz, B; Hutton, CP; Waddell, ID; Hitchin, JR; Smith, KM; Hamilton, NM PARG inhibitory compounds US Patent US10995073 Publication Date 5/4/2021 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
ADP-ribosylhydrolase ARH3 |
---|
Name: | ADP-ribosylhydrolase ARH3 |
Synonyms: | ADP-ribose glycohydrolase ARH3 | ADP-ribosylhydrolase 3 | ADPRHL2 | ADPRS | ADPRS_HUMAN | ARH3 | O-acetyl-ADP-ribose deacetylase ARH3 | Poly(ADP-ribose) glycohydrolase ARH3 | [Protein ADP-ribosylarginine] hydrolase-like protein 2 | [Protein ADP-ribosylserine] hydrolase |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 38934.22 |
Organism: | Homo sapiens (Human) |
Description: | Q9NX46 |
Residue: | 363 |
Sequence: | MAAAAMAAAAGGGAGAARSLSRFRGCLAGALLGDCVGSFYEAHDTVDLTSVLRHVQSLEP
DPGTPGSERTEALYYTDDTAMARALVQSLLAKEAFDEVDMAHRFAQEYKKDPDRGYGAGV
VTVFKKLLNPKCRDVFEPARAQFNGKGSYGNGGAMRVAGISLAYSSVQDVQKFARLSAQL
THASSLGYNGAILQALAVHLALQGESSSEHFLKQLLGHMEDLEGDAQSVLDARELGMEER
PYSSRLKKIGELLDQASVTREEVVSELGNGIAAFESVPTAIYCFLRCMEPDPEIPSAFNS
LQRTLIYSISLGGDTDTIATMAGAIAGAYYGMDQVPESWQQSCEGYEETDILAQSLHRVF
QKS
|
|
|
BDBM421626 |
---|
n/a |
---|
Name | BDBM421626 |
Synonyms: | 3-[5-(Difluoromethyl)-1,3,4-thiadiazol-2-yl]-6-fluoro-1-(2-fluoroethyl)-N-[1-(fluoromethyl)cyclopropyl]-2-oxo-benzimidazole-5-sulfonamide | US10508086, Example 216 | US10995073, Example 216 |
Type | Small organic molecule |
Emp. Form. | C16H14F5N5O3S2 |
Mol. Mass. | 483.436 |
SMILES | FCCn1c2cc(F)c(cc2n(-c2nnc(s2)C(F)F)c1=O)S(=O)(=O)NC1(CF)CC1 |
Structure |
|